From the Editors: Exclusive Training and Educational Opportunities for ISCT Members Wouter Van’t Hof, PhD Contributing Editor Cleveland Cord Blood Center, USA One of the unique benefits of ISCT membership is access to a variety of specialized training and educational opportunities...
North America Legal and Regulatory Affairs Watchdog Update August 2022 Kevin Bosse, PhD, RAC Elizabeth George, MS Nationwide Children's Hospital Columbus, OH, United States Co-Editors: Yossi Schwartz MD, MPH Mount Sinai Health System New York NY, United States Crystal Ruff...
ISCT & CMaT to roll out additional training programs following successful global launch of 'Workforce Development in Biomanufacturing' course The collaboration seeks to address the critical skilled labor shortage in the cell and gene therapy industry. Vancouver, Canada,...
LPC Snapshot - August 2022 Potency Testing in Cell and Gene Therapy Products By: Ted Kieffer, MD, MS Clinical Pathologist/Transfusion Medicine Specialist/Clinical Microbiologist Apheresis Collections Expert ISCT LPC ESP Member There has been a substantial discussion surrounding...
Industry Members in the News Funding from Ontario government launches OmniaBio Inc. OmniaBio Inc’s new facility will be the largest CDMO in Canada for the manufacture of CGTs March 31, 2022 (Toronto, ON) – OmniaBio Inc. , a subsidiary of CCRM, is the first project...
Member Spotlight: Qasim Rafiq, MEng, PhD, CEng, CSci Engineering the Future of CGT Research and Training By:Ashley Krull, PhD Telegraft Contributing Editor Mayo Clinic Rochester Rochester, United States Dr. Ashley Krull, of the Telegraft Hub Editorial Board sits down...
Cytotherapy Corner Report August 2022 Donald G. Phinney, PhD Senior Editor Department of Molecular Medicine UF Scripps Biomedical Research Jupiter, FL, USA In this issue of Cytotherapy Corner I want to highlight a white paper authored by Fink et al. ,...
2022 Year in Review - ISCT Committee Publications By: Rachel Burga, PhD Assistant Editor, Cytotherapy As the official translation journal of ISCT, Cytotherapy ’s vision is to publish novel and innovative results from high quality scientific and clinical...
From the President’s Desk: Regionalism Adds Depth to the ISCT I nternational Vision Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health The former...
Recent Initiatives in the Australia and New Zealand Region Gabrielle O’Sullivan PhD MPH Executive Officer, Royal Prince Alfred Hospital Institutional Biosafety Committee, Royal Prince Alfred Hospital Australia Giulia Giunti PhD Quality Manager, Malaghan Institute of Medical...